US3932465A
(en)
*
|
1970-07-08 |
1976-01-13 |
Ciba-Geigy Corporation |
3-R-methyl-7-amino-ceph-em-4-carboxylic acid compounds
|
JPS4948559B1
(tr)
*
|
1970-11-10 |
1974-12-21 |
|
|
US3987041A
(en)
*
|
1970-12-17 |
1976-10-19 |
Smithkline Corporation |
P-hydroxymethylphenylacetamidocephalosporins
|
US3855213A
(en)
*
|
1971-02-18 |
1974-12-17 |
Smith Kline French Lab |
3-heterocyclic thiomethyl-cephalosporins
|
US3867380A
(en)
*
|
1971-02-18 |
1975-02-18 |
Smithkline Corp |
3-Heterocyclic thiomethylcephalosporins
|
YU36967B
(en)
*
|
1971-01-18 |
1984-08-31 |
Bristol Myers Co |
Process for the production of antibacterial agents
|
IE36221B1
(en)
*
|
1971-04-21 |
1976-09-15 |
Ciba Geigy Ag |
Acylamino compounds and a process for their manufacture
|
US3757014A
(en)
*
|
1971-05-07 |
1973-09-04 |
Bristol Myers Co |
Ts 1,3,4 - oxadiazol-2-yl)thiomethyl)-3-cephem-4-carboxylic acid and sal7-(d-(alpha-amino-alpha-pheyle-acetamido)) - 3-(s-(5-hydroxymethyl -
|
GB1399086A
(en)
*
|
1971-05-14 |
1975-06-25 |
Glaxo Lab Ltd |
Cephalosporin compounds
|
US3903278A
(en)
*
|
1971-11-04 |
1975-09-02 |
Smithkline Corp |
Method of combating enterobacter infections
|
CA1076560A
(en)
*
|
1972-06-14 |
1980-04-29 |
Smith Kline And French Canada Ltd. |
3-heterocyclic thiomethylcephalosporins
|
US3968226A
(en)
*
|
1972-06-14 |
1976-07-06 |
Smithkline Corporation |
3-Heterocyclic thiomethylcephalosporins as antibacterial agents
|
CA999574A
(en)
*
|
1972-06-14 |
1976-11-09 |
Smith Kline And French Canada Ltd. |
7-hydroxyhalophenylacetamido-3-h heterocyclicthiomethyl cephalosporins
|
US3828037A
(en)
*
|
1972-07-20 |
1974-08-06 |
Smithkline Corp |
Trifluoromethylmercaptoacetamidocephalosporins
|
US3855212A
(en)
|
1972-08-04 |
1974-12-17 |
Squibb & Sons Inc |
Cyanomethylth ioacetylcephalosporins
|
US3957768A
(en)
*
|
1972-11-14 |
1976-05-18 |
Smithkline Corporation |
3-heterocyclicthiomethylcephalosporins
|
GB1438872A
(en)
*
|
1972-11-17 |
1976-06-09 |
Fujisawa Pharmaceutical Co |
7-beta-aminoacylamino-3-substituted-3-cephem-4-carboxylic acid derivatives and preparation thereof
|
YU36970B
(en)
*
|
1973-02-23 |
1984-08-31 |
Lilly Co Eli |
Process for obtaining 7-(amino)-acylamido-3-halocephalosporins
|
AR207752A1
(es)
*
|
1973-03-30 |
1976-10-29 |
Fujisawa Pharmaceutical Co |
Procedimiento para obtener acidos 7-amino-sustituido-3-tiometilsustituido-3-cefem-4-carboxilicos
|
US4007173A
(en)
*
|
1973-05-07 |
1977-02-08 |
Smithkline Corporation |
α-amino-α-(ureidophenyl)acetamidocephalosporins
|
AR205537A1
(es)
*
|
1973-05-10 |
1976-05-14 |
Fujisawa Pharmaceutical Co |
Procedimiento para la preparacion de derivados de acido 7-substituido fenilglicinamido - 3 - substituido - 3 - cefem - 4 - carboxilicos
|
US3962230A
(en)
*
|
1973-05-11 |
1976-06-08 |
Smithkline & French Laboratories, Inc. |
P-hydroxymethylphenylacetamidocephalosporins
|
US3879385A
(en)
*
|
1973-05-16 |
1975-04-22 |
American Home Prod |
3-(Alpha-trifluoromethylarylacetamido)-1,4-cyclo(1,-carboxyl)alkylenethio)-azetidin-2-one derivatives
|
US4000133A
(en)
*
|
1973-06-06 |
1976-12-28 |
Fujisawa Pharmaceutical Co., Ltd. |
Substituted 7-styryl-carbonyloxy-acetamido cephalosporanic
|
US3957985A
(en)
*
|
1973-07-05 |
1976-05-18 |
Smithkline Corporation |
Mandelamidocephalosporins with improved properties
|
US3884914A
(en)
*
|
1973-07-05 |
1975-05-20 |
Smithkline Corp |
Mandelamidocephalosporins with improved properties
|
US4022895A
(en)
*
|
1973-08-01 |
1977-05-10 |
Smithkline Corporation |
Substituted phenylglycylcephalosporins
|
US3957984A
(en)
*
|
1973-08-17 |
1976-05-18 |
Smithkline Corporation |
Substituted mercaptoacetamidocephalosporins
|
US3883520A
(en)
*
|
1973-08-17 |
1975-05-13 |
Smithkline Corp |
Substituted mercaptoacetamidocephalosporins
|
CH617703A5
(en)
*
|
1973-12-21 |
1980-06-13 |
Glaxo Operations Ltd |
Process for the preparation of the syn-isomer or of a mixture of syn- and anti-isomers of novel antibiotically active 7 beta -acylamino-ceph-3-em-4-carboxylic acids
|
DE2407715C2
(de)
*
|
1974-02-18 |
1982-12-02 |
Bayer Ag, 5090 Leverkusen |
Cephalosporine, Verfahren zu ihrer Herstellung sowie Arzneimittel
|
US4205166A
(en)
*
|
1974-02-20 |
1980-05-27 |
Fujisawa Pharmaceutical Co., Ltd. |
7-Substituted-3-aminoalkyl-, acylaminoalkyl-, or hydroxyalkyl-substituted heterocyclic thiomethyl-3-cephem-4-carboxylic acid derivatives and preparation thereof
|
US3928592A
(en)
*
|
1974-02-22 |
1975-12-23 |
Lilly Co Eli |
Antibiotic pharmaceutical compositions
|
JPS5729475B2
(tr)
*
|
1974-04-11 |
1982-06-23 |
|
|
US3925368A
(en)
*
|
1974-04-01 |
1975-12-09 |
Lilly Co Eli |
Acylureido substituted cephalosporins
|
US3956292A
(en)
*
|
1974-04-01 |
1976-05-11 |
Eli Lilly And Company |
7-(α-FUROYLUREIDOARYL AND CYCLOHEXADIENYLACETAMIDO) CEPHALOSPORIN ANTIBIOTICS
|
US3985747A
(en)
*
|
1974-05-24 |
1976-10-12 |
Bristol-Myers Company |
Crystalline sesquihydrate of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
|
GB1476981A
(en)
*
|
1974-06-05 |
1977-06-16 |
Bristol Myers Co |
Substituted penicillanic acids
|
US3928334A
(en)
*
|
1974-06-06 |
1975-12-23 |
Bristol Myers Co |
Process for the production of cefamandole
|
JPS612674B2
(tr)
*
|
1974-06-20 |
1986-01-27 |
Meiji Seika Co |
|
US3928337A
(en)
*
|
1974-08-07 |
1975-12-23 |
Bristol Myers Co |
Process for the production of cefamandole
|
CA1074784A
(en)
*
|
1974-09-06 |
1980-04-01 |
Sumitomo Chemical Company |
N-ACYLAMINO-.alpha.-ARYLACETAMIDO CEPHALOSPORINS
|
BE833640A
(fr)
*
|
1974-09-20 |
1976-03-19 |
|
Nouvelles cephalosporines et leur preparation
|
US4088815A
(en)
*
|
1974-09-20 |
1978-05-09 |
E. R. Squibb & Sons, Inc. |
3-Heterothio-7-ureido cephalosporins
|
US4018759A
(en)
*
|
1974-12-03 |
1977-04-19 |
Smithkline Corporation |
3-Heterocyclicthiomethylcephalosporins
|
US3992377A
(en)
*
|
1974-12-13 |
1976-11-16 |
Eli Lilly And Company |
3-Thio-substituted cephalosporin antibiotics
|
NO760358L
(tr)
*
|
1975-02-04 |
1976-08-05 |
Fujisawa Pharmaceutical Co |
|
IE44607B1
(en)
*
|
1975-03-18 |
1982-01-27 |
Smithkline Corp |
Cephalosporin compounds
|
US4006138A
(en)
*
|
1975-04-11 |
1977-02-01 |
Eli Lilly And Company |
Crystalline form of sodium O-formylcefamandole
|
US4092480A
(en)
*
|
1975-12-15 |
1978-05-30 |
Smithkline Corporation |
Intermediates for preparing substituted phenylglycylcephalosporins
|
US4054738A
(en)
*
|
1975-12-22 |
1977-10-18 |
Eli Lilly And Company |
Sodium cefamandole crystalline forms
|
US4127716A
(en)
*
|
1976-03-08 |
1978-11-28 |
E. R. Squibb & Sons, Inc. |
3-heterothiomethyl ureido cephalosporins
|
US4035361A
(en)
*
|
1976-03-17 |
1977-07-12 |
Eli Lilly And Company |
Bis-trimethylsilyl cefamandole and process therefor
|
US4063019A
(en)
|
1976-03-30 |
1977-12-13 |
E. R. Squibb & Sons, Inc. |
[[[(2,4-Dioxo-1-imidazolidinyl)amino]carbonyl]amino]-acetylcephalosporin derivatives
|
US4166115A
(en)
*
|
1976-04-12 |
1979-08-28 |
Fujisawa Pharmaceutical Co., Ltd. |
Syn 7-oxoimino substituted derivatives of cephalosporanic acid
|
US4112228A
(en)
*
|
1976-07-13 |
1978-09-05 |
Bristol-Myers Company |
7-(D-α-Hydroxy-2-arylacetamido)-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo-[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acids and derivatives
|
JPS5321191A
(en)
*
|
1976-08-10 |
1978-02-27 |
Shionogi & Co Ltd |
7-arylmalonamidocephem derivatives
|
DE2809058A1
(de)
*
|
1977-03-07 |
1978-09-14 |
Lilly Co Eli |
Verfahren zur herstellung von 3-(thiomethyl)cephalosporinen
|
US4144391A
(en)
*
|
1977-03-07 |
1979-03-13 |
Eli Lilly And Company |
Cephalosporin displacement reaction
|
US4115644A
(en)
*
|
1977-09-19 |
1978-09-19 |
Eli Lilly And Company |
Process for preparing pure cefamandole from alkali metal and ammonium salts thereof
|
AR223653A1
(es)
*
|
1977-09-27 |
1981-09-15 |
Toyama Chemical Co Ltd |
Procedimiento de preparacion del acido 7-(d(-)-alpha-(4-etil-2,3-dioxo-1-piperazinocarboxamido)-alpha-(4-hidroxifenil)acetamido)-3-(5-(1-metil-1,2,3,4-tetrazolil)tiometil)-delta3-cefem-4-carboxilico y su producto de adicion con n,n-dimetilacetamida
|
US4168376A
(en)
*
|
1978-06-05 |
1979-09-18 |
Eli Lilly And Company |
Process for crystalline sodium cefamandole
|
US4223135A
(en)
*
|
1979-03-19 |
1980-09-16 |
Bristol-Myers Company |
Production of cephalosporins
|
US4316017A
(en)
*
|
1979-03-19 |
1982-02-16 |
Bristol-Myers Company |
Cephalosporin intermediates
|
US4316016A
(en)
*
|
1979-03-19 |
1982-02-16 |
Bristol-Myers Company |
Cephalosporin intermediates
|
JPS55139387A
(en)
*
|
1979-04-19 |
1980-10-31 |
Yamanouchi Pharmaceut Co Ltd |
Novel synthetic method of 7-amino-3-heterocyclic thiomethyl-delta3-carboxylic acids
|
EP0047014B1
(en)
*
|
1980-09-02 |
1986-01-15 |
Asahi Kasei Kogyo Kabushiki Kaisha |
Novel thioesters and process for the preparation of the same
|
JPS5988490A
(ja)
*
|
1982-11-10 |
1984-05-22 |
Kyoto Yakuhin Kogyo Kk |
セフアロスポリン誘導体
|
US4737492A
(en)
*
|
1986-12-31 |
1988-04-12 |
Alcon Laboratories, Inc. |
Sparingly soluble salts of cefamandole, and ophthalmic compositions containing same
|
JPH0354585U
(tr)
*
|
1989-09-29 |
1991-05-27 |
|
|
US5318781A
(en)
*
|
1993-04-06 |
1994-06-07 |
Hoffmann-La Roche Inc. |
Absorption enhancement of antibiotics
|
FR2876379B1
(fr)
*
|
2004-10-08 |
2008-09-05 |
Isochem Sa |
Procede de polymerisation des o-carboxy anhydrides
|
WO2013057197A1
(en)
|
2011-10-20 |
2013-04-25 |
Dsm Sinochem Pharmaceuticals Netherlands B.V. |
Process for the formylation of cefamandole
|
WO2013057196A1
(en)
|
2011-10-20 |
2013-04-25 |
Dsm Sinochem Pharmaceuticals Netherlands B.V. |
Process for the preparation of cefamandole nafate
|
CN104193767B
(zh)
*
|
2014-08-07 |
2016-07-06 |
杭州长典医药科技有限公司 |
一种头孢孟多酯钠超细粉体制剂及其制备方法
|